Treatment-associated polymorphisms in protease are significantly associated with higher viral load and lower CD4 count in newly diagnosed drug-naive HIV-1 infected patients
about
A Population-Structured HIV Epidemic in Israel: Roles of Risk and EthnicityStrong Selection Significantly Increases Epistatic Interactions in the Long-Term Evolution of a ProteinCommentary on the role of treatment-related HIV compensatory mutations on increasing virulence: new discoveries twenty years since the clinical testing of protease inhibitors to block HIV-1 replication.Superinfection with drug-resistant HIV is rare and does not contribute substantially to therapy failure in a large European cohort.Treatment outcomes and their determinants in HIV patients on Anti-retroviral Treatment Program in selected health facilities of Kembata and Hadiya zones, Southern Nations, Nationalities and Peoples Region, EthiopiaCRF19_cpx is an Evolutionary fit HIV-1 Variant Strongly Associated With Rapid Progression to AIDS in Cuba.HIV-1 protease inhibitor drug resistance in Kenyan antiretroviral treatment-naive and -experienced injection drug users and non-drug users.Prevalence of Transmitted Drug-Resistance Mutations and Polymorphisms in HIV-1 Reverse Transcriptase, Protease, and gp41 Sequences Among Recent Seroconverters in Southern Poland.Decoding HIV resistance: from genotype to therapy.HIV-1 drug resistance: where do polymorphisms fit in?Molecular evolution of HIV-1 integrase during the 20 years prior to the first approval of integrase inhibitors.HIV-1 integrase strand-transfer inhibitor resistance in southern Taiwan.Virus genetic variability involvement in transmissibility of HIV-1 immune activation and disease progressionGenetic divergence of HIV-1 B subtype in Italy over the years 2003-2016 and impact on CTL escape prevalence
P2860
Q28547440-AFCAD19B-C3D3-471B-A63D-3AD0CC40741DQ28551065-AF2DF9E1-5E1C-48C8-B095-45DCEBFF5A5AQ34432377-A3B64982-B8CC-4A8F-BF47-35FC4A01E1C3Q35039280-EE0E4800-3FB1-4F6D-A657-A3ED9245861CQ35756709-F3707EFB-3A1A-4887-ABD8-74FB6B956C4AQ35795095-04B1F6D4-D7EB-4912-8F78-8B246F286A1BQ35957224-5C823B1A-DA38-4F7C-9934-683A74BE81CBQ37643256-9FD3A23E-44C1-4BBA-BC02-B912C9C56E52Q38632663-4CD5F425-CFC7-4906-AF63-AD4E52139912Q46366172-F85AA6B5-0E7D-4335-BD3B-E4B3A5CEEA7BQ47130258-D90AEF29-584A-4B43-937F-01F03A568487Q55060074-8E01574F-BEA2-4AA2-9B56-0AF89CA3C614Q56451330-774BAEB9-5324-4A96-8723-A1986E9FB3B6Q57794708-81EDA5F9-C91B-4A3E-9B93-8FF7854C04DA
P2860
Treatment-associated polymorphisms in protease are significantly associated with higher viral load and lower CD4 count in newly diagnosed drug-naive HIV-1 infected patients
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Treatment-associated polymorph ...... -naive HIV-1 infected patients
@ast
Treatment-associated polymorph ...... -naive HIV-1 infected patients
@en
type
label
Treatment-associated polymorph ...... -naive HIV-1 infected patients
@ast
Treatment-associated polymorph ...... -naive HIV-1 infected patients
@en
prefLabel
Treatment-associated polymorph ...... -naive HIV-1 infected patients
@ast
Treatment-associated polymorph ...... -naive HIV-1 infected patients
@en
P2093
P2860
P50
P356
P1433
P1476
Treatment-associated polymorph ...... -naive HIV-1 infected patients
@en
P2093
Andrzei Horban
Annemarie Mj Wensing
Birgitta Asjö
Charles Ab Boucher
Chiara Riva
Claudia Kücherer
Claus Nielsen
Danica Stanekova
Daniel Struck
David Amc van de Vijver
P2860
P2888
P356
10.1186/1742-4690-9-81
P50
P577
2012-10-03T00:00:00Z
P5875
P6179
1020054992